Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submission - statnews.com
Regenxbio said its experimental gene therapy for Duchenne muscular dystrophy succeeded in a trial, paving the way for a submission to the FDA.
Comments